Clinical Trials Directory

Trials / Unknown

UnknownNCT04148053

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis

Evaluation of TB-antigen Responsive T Cell Markers in Diagnosis of Tuberculosis and Extrapulmonary Tuberculosis

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Tongji University · Academic / Other
Sex
All
Age
7 Years – 90 Years
Healthy volunteers
Accepted

Summary

Diagnosis of active and latent pulmonary tuberculosis, as well as extrapulmonary tuberculosis, is still a major challenge of TB control in China. This observational study aims to evaluate TB-antigen responsive T cell markers in the diagnosis of tuberculosis and extrapulmonary tuberculosis and try to find new prompt and cost-effective laboratory tests for active TB screening.

Detailed description

The enrolled patients will be grouped into active or latent tuberculosis according to the bacteriological evidence of TB. The TB-antigen responsive T cell markers will be examined. The performance of each T cell marker for the diagnosis of active TB will be systematically evaluated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTB-antigen responsive T cell markersA blood test including a series of T cell markers which are responsive to TB antigens

Timeline

Start date
2018-11-01
Primary completion
2019-12-31
Completion
2020-03-01
First posted
2019-11-01
Last updated
2019-11-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04148053. Inclusion in this directory is not an endorsement.